Stream Co.,Ltd. (TYO:3071)

Verve Therapeutics Ratios and Metrics

Market cap in millions JPY. Fiscal year is February - January.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 1, 2025	Jan 31, 2025	Jan 31, 2024	Jan 31, 2023	Jan 31, 2022	Jan 31, 2021
Market Capitalization	3,095	2,847	3,095	3,084	3,220	5,758
Market Cap Growth	-5.50%	-8.04%	0.38%	-4.24%	-44.08%	154.22%
Enterprise Value	2,629	2,906	3,129	2,393	2,911	5,436
Last Close Price	112.00	103.00	109.03	107.20	109.10	190.44
PE Ratio	147.39	711.64	103.18	14.15	6.22	10.10
PS Ratio	0.10	0.09	0.11	0.10	0.11	0.21
PB Ratio	1.06	0.98	1.04	1.03	1.12	2.43
P/TBV Ratio	1.21	1.12	1.19	1.18	1.31	2.91
P/FCF Ratio	12.04	3.06	-	25.48	4.67	9.76
P/OCF Ratio	11.72	3.02	-	20.98	4.49	9.38
EV/Sales Ratio	0.08	0.10	0.11	0.08	0.10	0.19
EV/EBITDA Ratio	5.58	6.54	8.87	4.38	3.41	6.63
EV/EBIT Ratio	9.13	11.18	17.19	6.25	4.18	8.21
EV/FCF Ratio	10.23	3.12	-	19.77	4.22	9.21
Debt / Equity Ratio	0.14	0.29	0.40	0.22	0.41	0.55
Debt / EBITDA Ratio	0.87	1.90	3.34	1.19	1.39	1.59
Debt / FCF Ratio	1.60	0.90	-	5.39	1.73	2.21
Asset Turnover	4.73	4.84	4.37	4.32	4.42	4.89
Inventory Turnover	9.05	9.23	8.14	8.94	9.20	8.98
Quick Ratio	0.71	0.80	0.71	0.84	0.83	0.83
Current Ratio	1.58	1.65	1.70	1.75	1.50	1.57
Return on Equity (ROE)	0.51%	-0.07%	0.84%	7.07%	19.73%	27.02%
Return on Assets (ROA)	2.75%	2.60%	1.81%	3.42%	6.34%	7.21%
Return on Capital (ROIC)	5.44%	4.10%	2.91%	6.20%	11.24%	12.72%
Return on Capital Employed (ROCE)	9.30%	8.50%	5.80%	11.80%	21.70%	23.60%
Earnings Yield	0.68%	0.14%	0.97%	7.07%	16.09%	9.90%
FCF Yield	8.30%	32.71%	-21.74%	3.92%	21.40%	10.25%
Dividend Yield	2.68%	2.91%	2.75%	2.80%	2.75%	-
Payout Ratio	390.48%	2050.00%	270.00%	37.16%	-	-
Buyback Yield / Dilution	-0.07%	-0.39%	-0.88%	-	-	-
Total Shareholder Return	2.61%	2.53%	1.87%	2.80%	2.75%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.